Stocks360

Filament Health Corp. (FH.NE)

Stock analysis · NEO · Healthcare · Drug Manufacturers - Specialty & Generic

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.72
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Filament Health Corp. (FH.NE) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Earnings

Most Recent
Apr 3, 2023
EPS $-0.07 vs est. $-0.02
Missed by $0.05

Proprietary Signals

Signal snapshot temporarily unavailable.

About Filament Health Corp.

Filament Health Corp. focuses on the discovery and advanced extraction of natural psychedelic compounds. The firm actively cultivates psychedelic flora, conducts genetic investigations, develops extraction methodologies, and performs internal clinical trials. It then supplies its intellectual property and potential pharmaceutical agents to drug developers, scientific researchers, and other authorized organizations. Its corporate headquarters are located in Vancouver, Canada.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap